JAK2 and cervical cancer: MiR-126 can inhibit the expression of MMP2 by targeting ZEB1, which inhibits the protein expression of p-JAK2 and p-STAT3 and inactivates the JAK2/STAT3 signaling pathway, which inhibits the proliferation, migration and invasion of cervical cancer cells 65.